Andere Sprachen 180 Life Sciences Corp.

Aktien

A404NG

US68236V3024

KBLM

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:00 29.04.2024			% 5 Tage	% 1. Jan.
1,96 ^USD	+8,89 %		+8,89 %	-51,68 %

25.03.	180 Life Sciences Corp. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
11.03.	180 Life Sciences Corp. kündigt Änderungen im Vorstand an	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

180 Life Sciences Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	25.03.
180 Life Sciences : Corporate Presentation	15.03.
180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement	14.03.
180 Life Sciences Corp. Announces Board Changes	11.03.
180 Life Sciences Corp. Appoints Blair Jordan as A Member of the Board of Directors	29.02.
180 Life Sciences to Conduct 1-For-19 Reverse Stock Split	26.02.
180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance Plan	26.02.
180 Life Sciences Corp. announced a financing transaction	21.02.
180 Life Sciences Corp. Announces Board Resignations	21.12.
180 Life Sciences Corp. Announces Resignation of Donald A. Mcgovern, as Member of the Board of Directors	20.12.
180 Life Sciences Hires Financial Adviser to Help Explore Strategic Alternatives	04.12.
180 Life Sciences Engages Financial Advisor to Explore Strategic Alternatives	04.12.
180 Life Sciences Engages Financial Advisor to Explore Strategic Alternatives	04.12.
180 Life Sciences : Material Agreement - Form 8-K	29.11.
180 Life Sciences Announces Review of Strategic Alternatives	28.11.
180 Life Sciences Announces Review of Strategic Alternatives	28.11.
Certain Warrants of 180 Life Sciences Corp. are subject to a Lock-Up Agreement Ending on 13-NOV-2023.	13.11.
Certain Stock Options of 180 Life Sciences Corp. are subject to a Lock-Up Agreement Ending on 13-NOV-2023.	13.11.
Certain Common Stock of 180 Life Sciences Corp. are subject to a Lock-Up Agreement Ending on 13-NOV-2023.	13.11.
180 Life Sciences Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen 180 Life Sciences Corp.

Aktien

A404NG

US68236V3024

KBLM

Andere Sprachen

Filter